Besta F - Search Results

1

Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice.

Massberg S, Grüner S, Konrad I, Garcia Arguinzonis MI, Eigenthaler M, Hemler K, Kersting J, Schulz C, Muller I, Besta F, Nieswandt B, Heinzmann U, Walter U, Gawaz M. Massberg S, et al. Among authors: besta f. Blood. 2004 Jan 1;103(1):136-42. doi: 10.1182/blood-2002-11-3417. Epub 2003 Aug 21. Blood. 2004. PMID: 12933589 Free article.

2

Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.

Massberg S, Konrad I, Bültmann A, Schulz C, Münch G, Peluso M, Lorenz M, Schneider S, Besta F, Müller I, Hu B, Langer H, Kremmer E, Rudelius M, Heinzmann U, Ungerer M, Gawaz M. Massberg S, et al. Among authors: besta f. FASEB J. 2004 Feb;18(2):397-9. doi: 10.1096/fj.03-0464fje. Epub 2003 Dec 4. FASEB J. 2004. PMID: 14656994

3

Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement.

Müller I, Besta F, Schulz C, Massberg S, Schönig A, Gawaz M. Müller I, et al. Among authors: besta f. Thromb Haemost. 2003 May;89(5):783-7. Thromb Haemost. 2003. PMID: 12719773

4

Effects of statins on platelet inhibition by a high loading dose of clopidogrel.

Müller I, Besta F, Schulz C, Li Z, Massberg S, Gawaz M. Müller I, et al. Among authors: besta f. Circulation. 2003 Nov 4;108(18):2195-7. doi: 10.1161/01.CIR.0000099507.32936.C0. Epub 2003 Oct 20. Circulation. 2003. PMID: 14568892 Clinical Trial.

5

Effects of 2 different antiplatelet regimens with abciximab or tirofiban on platelet function in patients undergoing coronary stenting.

Massberg S, Mueller I, Besta F, Thomas P, Gawaz M. Massberg S, et al. Among authors: besta f. Am Heart J. 2003 Nov;146(5):E19. doi: 10.1016/S0002-8703(03)00368-5. Am Heart J. 2003. PMID: 14597948 Clinical Trial.

6

Combined antithrombotic therapy for acute coronary syndrome.

Gawaz M, Müller I, Besta F. Gawaz M, et al. Among authors: besta f. Semin Vasc Med. 2003 May;3(2):163-76. doi: 10.1055/s-2003-40674. Semin Vasc Med. 2003. PMID: 15199479 Review.

7

Reduced beta3-endonexin levels are associated with enhanced urokinase-type plasminogen activator receptor expression in ApoE-/- mice.

Besta F, Müller I, Lorenz M, Massberg S, Bültmann A, Cabeza N, Richter T, Kremmer E, Nothdurfter C, Brand K, Gawaz M. Besta F, et al. Thromb Res. 2004;114(4):283-92. doi: 10.1016/j.thromres.2004.02.021. Thromb Res. 2004. PMID: 15381392

8

Role of beta(3)-endonexin in the regulation of NF-kappaB-dependent expression of urokinase-type plasminogen activator receptor.

Besta F, Massberg S, Brand K, Müller E, Page S, Grüner S, Lorenz M, Sadoul K, Kolanus W, Lengyel E, Gawaz M. Besta F, et al. J Cell Sci. 2002 Oct 15;115(Pt 20):3879-88. doi: 10.1242/jcs.00081. J Cell Sci. 2002. PMID: 12244126

9

The NITY motif of the beta-chain cytoplasmic domain is involved in stimulated internalization of the beta3 integrin A isoform.

Gawaz M, Besta F, Ylänne J, Knorr T, Dierks H, Böhm T, Kolanus W. Gawaz M, et al. Among authors: besta f. J Cell Sci. 2001 Mar;114(Pt 6):1101-13. doi: 10.1242/jcs.114.6.1101. J Cell Sci. 2001. PMID: 11228154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters